In these instances, administering NAMPT inhibitors in combination with NA is postulated to help many healthy, NAPRT-proficient tissues, but not NAPRT-deficient cancer cells in avoiding the consequences of NAMPT obstruction. This evidence concerns the gene NAMPT and cancer.